Weicheng Kong
Papers
1
Total Citations
6
H-Index
1
About
Weicheng Kong is a leading thoracic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for lung cancer treatment, with a particular focus on robotic and thoracoscopic approaches. His major contributions lie in rigorously comparing the oncologic outcomes of these two modalities, especially regarding lymph node dissection quality and recurrence patterns. In a landmark 2024 study drawing on eleven years of real-world data from a high-volume center, Kong demonstrated that robotic lobectomy achieves superior lymph node dissection quality and significantly reduces early recurrence rates compared to thoracoscopic lobectomy for stage N1-2 non-small cell lung cancer—a finding with immediate clinical implications for surgical decision-making. This work, already garnering 6 citations shortly after publication, underscores his impact on refining surgical standards. Beyond this, Kong’s research portfolio systematically addresses key challenges in thoracic oncology, from optimizing perioperative protocols to improving long-term survival outcomes. His evidence-based insights are shaping how surgeons balance technical precision with oncologic efficacy, making him a pivotal voice in the evolution of lung cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1